Search papers, labs, and topics across Lattice.
This study introduces EEG-FuseFormer, a transformer-driven feature fusion framework designed for predicting seizure onset in epilepsy patients by integrating features from CNN-LSTM and ResNet-18 architectures. The model achieves a remarkable mean recall of 98.85% on the CHB-MIT dataset, significantly outperforming existing state-of-the-art methods while demonstrating improved generalization in cross-patient testing scenarios. Additionally, the research evaluates the model's performance-complexity trade-off across various hardware platforms, underscoring its practical applicability in real-world settings.
Achieving a mean recall of 98.85%, EEG-FuseFormer sets a new benchmark for seizure onset prediction by effectively leveraging transformer-based feature fusion.
Epilepsy is one of the most common neurological disorders globally, characterized by recurring seizures and significantly impacting the quality of life. Despite advancements in diagnostic techniques, the mitigation of risks faced by epilepsy patients remains challenging due to the unpredictability of seizure events. An accurate forecast of seizure onset helps to reduce risks in epilepsy patients. In this paper, we propose EEG-FuseFormer, a transformer-based feature fusion framework for seizure-onset prediction that combines intermediate features extracted from Convolutional Neural Networks-Long Short-Term Memory (CNN-LSTM) and ResNet-18 networks. The CNN-LSTM architecture captures both spatial and temporal features directly from the raw signal, whereas the ResNet-18 extracts features from the Short-Time Fourier Transform (STFT) representation of the EEG signals. Fusion is carried out using a transformer encoder, and the final prediction is generated using fully connected dense layers. The CHB-MIT dataset was used to validate the proposed model. The results show that the proposed model achieves a mean recall of 98.85% and outperforms most of the state-of-the-art methods. This study evaluates the ability of the proposed feature fusion model to generalize in cross-patient testing scenarios. Fine-tuning pre-trained models on limited target patient data (target adaptation) within the cross-patient validation framework results in higher recall, precision, and F1-score metrics in comparison to the conventional cross-patient validation approach. Finally, the runtime-based computational complexity of the model is assessed across diverse hardware platforms to highlight the performance-complexity trade-off.
NUS